4.6 Article

Race, Interleukin-6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Change in Cardiac Biomarkers and Risk of Incident Heart Failure and Atrial Fibrillation in CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

Nisha Bansal et al.

Summary: In chronic kidney disease (CKD), increases in NT-proBNP were significantly associated with greater risk of incident HF and AF, and increases in sST2 were associated with HF. Further studies should investigate whether these markers of subclinical cardiovascular disease can be modified to reduce the risk of cardiovascular disease in CKD.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Article Urology & Nephrology

Ziltivekimab for Treatment of Anemia of Inflammation in Patients on Hemodialysis: Results from a Phase 1/2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Pablo E. Pergola et al.

Summary: Ziltivekimab significantly improved markers of inflammation, reduced ESA requirements, and increased serum albumin in hemodialysis patients with inflammation and hyporesponsiveness to ESA therapy.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Article Medicine, General & Internal

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Paul M. Ridker et al.

Summary: This study investigated the safety and efficacy of IL-6 inhibition treatment in high cardiovascular risk individuals. Results showed that ziltivekimab effectively reduced biomarkers of inflammation and thrombosis, with promising effects observed in patients with chronic kidney disease.

LANCET (2021)

Article Cardiac & Cardiovascular Systems

Diminished Returns of Educational Attainment on Heart Disease among Black Americans

Shervin Assari et al.

OPEN CARDIOVASCULAR MEDICINE JOURNAL (2020)

Article Medical Laboratory Technology

Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study)

Tanja B. Grammer et al.

CLINICAL CHEMISTRY (2019)

Article Urology & Nephrology

Survival Advantage in Black Versus White Men With CKD: Effect of Estimated GFR and Case Mix

Csaba P. Kovesdy et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2013)

Article Multidisciplinary Sciences

Inflammation Regulates TMPRSS6 Expression via STAT5

Delphine Meynard et al.

PLOS ONE (2013)

Article Public, Environmental & Occupational Health

Correlates of Coronary Artery Calcified Plaque in Blacks and Whites with Type 2 Diabetes

Lynne E. Wagenknecht et al.

ANNALS OF EPIDEMIOLOGY (2011)

Article Genetics & Heredity

Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)

Karin E. Finberg et al.

NATURE GENETICS (2008)

Article Urology & Nephrology

Survival advantage of black patients with kidney disease after acute myocardial infarction

Britt B. Newsome et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Article Transplantation

Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients

Nataliya Volkova et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)

Article Urology & Nephrology

IL-6 haplotypes, inflammation, and risk for cardiovascular disease in a multiethnic dialysis cohort

Yongmei Liu et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)

Article Medicine, General & Internal

Cardiovascular mortality risk in chronic kidney disease - Comparison of traditional and novel risk factors

MG Shlipak et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Psychiatry

Finding our way: An introduction to path analysis

DL Streiner

CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2005)